Aminopeptidase N (APN/CD13) as a target for anti-cancer agent design.
about
Discovery of α,β- and α,γ-diamino acid scaffolds for the inhibition of M1 family aminopeptidasesThe Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach.Aminopeptidase N (CD13) as a target for cancer chemotherapy.An integrated approach to the ligand binding specificity of Neisseria meningitidis M1 alanine aminopeptidase by fluorogenic substrate profiling, inhibitory studies and molecular modeling.Structure-guided, single-point modifications in the phosphinic dipeptide structure yield highly potent and selective inhibitors of neutral aminopeptidases.Aminopeptidase N (EC 3.4.11.2) inhibitors (2006 - 2010): a patent review.Adeno-associated virus (AAV) vectors in cancer gene therapy.A particular expression pattern of CD13 epitope 7H5 in chronic lymphocytic leukaemia--a possible new therapeutic target.Design, synthesis and biological evaluation of novel L-isoserine tripeptide derivatives as aminopeptidase N inhibitors.Design, synthesis and preliminary activity evaluation of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as aminopeptidase N/CD13 inhibitors.LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.Melflufen - a peptidase-potentiated alkylating agent in clinical trials.APN/CD13 is over-expressed by Psoriatic fibroblasts and is modulated by CGRP and IL-4 but not by retinoic acid treatment.The first ratiometric fluorescent probe for aminopeptidase N
P2860
Q27675209-CE51758A-20EA-452C-907D-830DC8CE3587Q33683970-13AE242F-B254-45E8-AB83-A8578D66E1AAQ34157418-F2082883-93C5-4183-93F2-507CD0625E76Q34468476-2F6B28AD-2390-4CF8-A8F3-DE799FC16278Q35090932-F2B6A36E-08F2-429E-AD61-7BFC833EAD43Q37880899-73EEB126-1751-4E7D-8FAB-EC1CF260C8ECQ38706321-E9C46AC2-EB05-4221-B531-CF443C9B59C2Q39337522-8BC64D1E-5971-4A61-B2ED-AE00B7E5E90EQ39356388-D65FFA87-D437-4390-BB6F-78B83FE35238Q39387611-5D29EE30-D68C-43C4-B6F5-904462C1E958Q39746499-F7BBACC2-9152-443D-9F34-A4F47B812D5DQ42371678-DFD8A859-5533-46CB-9B7D-D5F51B4FFF95Q48306414-58659171-C22C-4BA3-910F-8CA1764C7B69Q58860306-69A0E4C9-AACA-4123-B7DE-1A761BFAF52C
P2860
Aminopeptidase N (APN/CD13) as a target for anti-cancer agent design.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aminopeptidase N (APN/CD13) as a target for anti-cancer agent design.
@en
Aminopeptidase N
@nl
type
label
Aminopeptidase N (APN/CD13) as a target for anti-cancer agent design.
@en
Aminopeptidase N
@nl
prefLabel
Aminopeptidase N (APN/CD13) as a target for anti-cancer agent design.
@en
Aminopeptidase N
@nl
P1476
Aminopeptidase N (APN/CD13) as a target for anti-cancer agent design.
@en
P2093
Wenfang Xu
Xiaopan Zhang
P304
P356
10.2174/092986708786242840
P577
2008-01-01T00:00:00Z